LGI steam bread
Dietary SupplementLGI Steam bread called "Mangu"steam bread
NCT Number: NCT06512090
This was a single-center, randomized, open, prospective, parallel-controlled, head-to-head comparison trial. To investigate the effects of low glycemic index(LGI)related steam bread on glycemic control,islet function in patients with type 2 diabetes.
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
LGI Steam bread called "Mangu"steam bread
the calorie intake of Diabetic diet will by recommended by nutritionist
Time frame: 120 minutes
the blood glucose level at 120 mins after Standard meal test
Time frame: 60 minutes
The blood glucose at 60 mins after standard meal test
Time frame: 120 minutes
120-minute Area under the Curve (iAUC)
Contact information is provided by the study sponsor or research team.
Shanghai Punan Hospital of Pudong New District
Other
To Investigate the Effects of Low Glycemic Index(LGI)Related Steamed Bread on Glycemia Control, Islet Function in Patients With Type 2 Diabetes in China: A Single-center, Randomized, Open-label, Prospective Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07794254
Diabete Mellitus, Diabete Type 2
Beijing, Beijing Municipality, China
View Trial DetailsNCT07344324
Body Weight, Diabete Type 2
View Trial DetailsNCT07739537
Diabete Type 2, Diabetes Mellitus
View Trial DetailsNCT07730567
Diabete Type 2, Diabetes Mellitus
Seoul, South Korea
View Trial Details